Normunity (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- January 13, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $75,000,000
Company Info
- Founders
- Rachel Humphrey
- Company Description
- Normunity develops precision immuno-oncology medicines that enable normal immunity against cancer.
- Market
- Anti-cancer therapies
- Location
- New Haven, Connecticut, USA
- Coinvestors
- Canaan Partners, Connecticut Innovations, Enavate Sciences, Hong Kong Inno Capital, HongShan Capital Group, Osage Venture Partners, Pfizer Venture Investments, Regeneron Ventures, Samsara BioCapital, Sanofi Ventures, Taiho Ventures, YK Bioventures